| scholarly article | Q13442814 |
| P50 | author | Pal Pacher | Q30347235 |
| Partha Mukhopadhyay | Q37379024 | ||
| Jacek Zielonka | Q42361316 | ||
| Zsuzsanna K Zsengeller | Q59157435 | ||
| P2093 | author name string | Vivek Patel | |
| Balaraman Kalyanaraman | |||
| Joy Joseph | |||
| Samir M Parikh | |||
| Isaac E Stillman | |||
| Béla Horváth | |||
| Galin Tanchian | |||
| Malek Kechrid | |||
| Eileen Holovac | |||
| P2860 | cites work | Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury | Q24595633 |
| Nitric oxide and peroxynitrite in health and disease | Q24645400 | ||
| Peroxynitrite: biochemistry, pathophysiology and development of therapeutics | Q29615424 | ||
| Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity | Q29616651 | ||
| Cellular processing of platinum anticancer drugs | Q29617899 | ||
| Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models | Q30487260 | ||
| Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy | Q33847549 | ||
| The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone | Q34251106 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity | Q34690068 | ||
| Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury | Q35012392 | ||
| Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates | Q35082127 | ||
| Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury | Q35514172 | ||
| Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer | Q35572426 | ||
| Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury | Q35628316 | ||
| TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity | Q36662114 | ||
| Cisplatin nephrotoxicity: mechanisms and renoprotective strategies | Q37084089 | ||
| Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants | Q37352307 | ||
| Mitochondria-targeted antioxidants as therapies. | Q37847660 | ||
| Mitochondria-targeted small molecule therapeutics and probes | Q37851996 | ||
| TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity | Q39738416 | ||
| Cancer therapy and renal injury | Q39738464 | ||
| Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure | Q39798874 | ||
| Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. | Q40765619 | ||
| Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death | Q44242746 | ||
| Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. | Q44333806 | ||
| Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells | Q44610333 | ||
| Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis | Q44737321 | ||
| Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study | Q44976163 | ||
| Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. | Q46425691 | ||
| Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide | Q46638801 | ||
| Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice | Q46655135 | ||
| Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. | Q52552262 | ||
| TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. | Q53923667 | ||
| Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury | Q58376211 | ||
| Peroxynitrite formation from macrophage-derived nitric oxide | Q67505344 | ||
| Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells | Q80066103 | ||
| PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G | Q80388628 | ||
| P433 | issue | 2 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 497-506 | |
| P577 | publication date | 2011-11-10 | |
| P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
| P1476 | title | Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy | |
| P478 | volume | 52 |
| Q57212507 | (E)-2-benzylidene-4-phenyl-1,3-diselenole ameliorates signals of renal injury induced by cisplatin in rats |
| Q91672673 | A Single-Center Retrospective Study of Acute Kidney Injury Incidence in Patients With Advanced Malignancies Treated With Antimitochondrial Targeted Drug |
| Q38098184 | A review on the role of quinones in renal disorders |
| Q89379363 | Aged kidney: can we protect it? Autophagy, mitochondria and mechanisms of ischemic preconditioning |
| Q46365540 | Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna |
| Q21090597 | Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence |
| Q36327667 | Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin. |
| Q35767081 | Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism |
| Q28546838 | Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways |
| Q39325631 | Boronate probes as diagnostic tools for real time monitoring of peroxynitrite and hydroperoxides. |
| Q46935178 | C-phycocyanin prevents cisplatin-induced nephrotoxicity through inhibition of oxidative stress |
| Q35707221 | Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis |
| Q30277374 | Cellular and Molecular Mechanisms of AKI. |
| Q28535275 | Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions |
| Q46472909 | Cisplatin induces mitochondrial deficits in Drosophila larval segmental nerve. |
| Q36285862 | Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity |
| Q34411477 | Computational modeling of apoptotic signaling pathways induced by cisplatin |
| Q48247138 | Cytoprotective Effects of Cell-Permeable Bifunctional Antioxidant Enzyme, GST-TAT-SOD, against Cisplatin-Induced Cell Damage. |
| Q39933592 | Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties |
| Q36339445 | Drug-induced mitochondrial dysfunction and cardiotoxicity |
| Q46363812 | Effect of long-term maternal smoking on the offspring's lung health |
| Q33584645 | Effect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of action |
| Q37592492 | Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy |
| Q50850318 | Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury. |
| Q38345872 | Fetal programming of chronic kidney disease: the role of maternal smoking, mitochondrial dysfunction, and epigenetic modfification. |
| Q52564368 | Horseradish Peroxidase-Encapsulated Hollow Silica Nanospheres for Intracellular Sensing of Reactive Oxygen Species. |
| Q55456883 | IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity. |
| Q37142629 | Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function |
| Q55352403 | Interplay of Oxidative Stress, Inflammation, and Autophagy: Their Role in Tissue Injury of the Heart, Liver, and Kidney. |
| Q41367987 | L-thyroxine modifies nephrotoxicity by regulating the apoptotic pathway: The possible role of CD38/ADP-ribosyl cyclase-mediated calcium mobilization. |
| Q33874691 | Late-onset Mitochondrial Cardiomyopathy Triggered by Anticancer Treatment |
| Q42076578 | Lipid peroxidative damage on Cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. |
| Q98224533 | Manganese Superoxide Dismutase Dysfunction and the Pathogenesis of Kidney Disease |
| Q35738714 | Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation |
| Q64071206 | Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury |
| Q35912784 | Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation. |
| Q28484886 | MitoQ blunts mitochondrial and renal damage during cold preservation of porcine kidneys |
| Q54957106 | MitoQ supplementation prevent long-term impact of maternal smoking on renal development, oxidative stress and mitochondrial density in male mice offspring. |
| Q48026176 | Mitochondria Damage and Kidney Disease |
| Q38809996 | Mitochondria in Acute Kidney Injury |
| Q44695027 | Mitochondria-Targeted Antioxidant Mitoquinone Reduces Cisplatin-Induced Ototoxicity in Guinea Pigs |
| Q26744639 | Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury |
| Q93385793 | Mitochondria-Targeted Drugs |
| Q39400621 | Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. |
| Q36979129 | Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death |
| Q37093677 | Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cells |
| Q38237988 | Mitochondria-targeted therapies for acute kidney injury |
| Q34771531 | Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death |
| Q55214653 | Mitochondrial NADP+-dependent isocitrate dehydrogenase deficiency increases cisplatin-induced oxidative damage in the kidney tubule cells. |
| Q37686261 | Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? |
| Q26824709 | Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications |
| Q33793389 | Mitochondrial dysfunction in inherited renal disease and acute kidney injury |
| Q99636706 | Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches |
| Q34762287 | Mitochondrial dysregulation and protection in cisplatin nephrotoxicity |
| Q28546437 | Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice |
| Q102379536 | Mitochondrial quality control in kidney injury and repair |
| Q36203242 | Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. |
| Q92258393 | Myricetin Abrogates Cisplatin-Induced Oxidative Stress, Inflammatory Response, and Goblet Cell Disintegration in Colon of Wistar Rats |
| Q35745097 | Neuroprotective Effects of Mitochondria-Targeted Plastoquinone and Thymoquinone in a Rat Model of Brain Ischemia/Reperfusion Injury |
| Q37022931 | Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity. |
| Q33849235 | PGC-1α attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3β inactivation mediated by activated p38 in HK-2 Cells |
| Q47938445 | PGC1α in the kidney |
| Q34396286 | Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity |
| Q57191109 | Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease |
| Q42361936 | Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review |
| Q47884254 | Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury |
| Q39420751 | Protective Role for Antioxidants in Acute Kidney Disease |
| Q37479069 | Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice |
| Q43111489 | Protective effects of icariin on cisplatin-induced acute renal injury in mice |
| Q36275825 | Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway |
| Q47221866 | QiShenYiQi Pills, a Compound Chinese Medicine, Prevented Cisplatin Induced Acute Kidney Injury via Regulating Mitochondrial Function |
| Q94594727 | Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity |
| Q51137792 | Renoprotective effects of antioxidants against cisplatin nephrotoxicity. |
| Q26765518 | Role of endoplasmic reticulum stress in drug-induced toxicity |
| Q53803132 | Safety assessment and attenuation of cisplatin induced nephrotoxicity by tuberous roots of Boerhaavia diffusa. |
| Q38127618 | Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy |
| Q64899999 | TFEB-driven lysosomal biogenesis is pivotal for PGC1α-dependent renal stress resistance. |
| Q28083205 | Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy |
| Q64052750 | Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis |
| Q38982099 | Taurine rescues cisplatin-induced muscle atrophy in vitro: a morphological study |
| Q30457536 | Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria. |
| Q39252634 | The Emerging Role of Mitochondrial Targeting in Kidney Disease |
| Q89896008 | The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases |
| Q36506869 | The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity |
| Q43531461 | The plant decapeptide OSIP108 can alleviate mitochondrial dysfunction induced by cisplatin in human cells. |
| Q53061845 | The protective effect of selenium in cisplatin-related retinotoxicity. |
| Q51678747 | The protective effect of trimetazidine against cisplatin-induced nephrotoxicity in rats. |
| Q55066483 | The targeted anti-oxidant MitoQ causes mitochondrial swelling and depolarization in kidney tissue. |
| Q34024870 | Therapeutic targeting of the mitochondrial dysfunction in septic acute kidney injury |
| Q38819202 | Vanadium(III)-L-cysteine protects cisplatin-induced nephropathy through activation of Nrf2/HO-1 pathway |
| Q35854652 | β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner |
Search more.